Video

CDC Guidelines and Detecting C. Difficile Infection

Author(s):

The CDC has standardized guidelines to help diagnose diarrhea, a potential indicator of c. difficile infection.

Unnecessarily isolating individuals due to suspected c. difficile infection (CDI) can place a financial burden on the healthcare system as well as cause emotional toil for the patient. Thus, it becomes all the more imperative to determine risk factors for CDI.

In an interview with HCPLive®, Michelle Thomas, MD, of Harlem Hospital Center, discussed the US Centers for Disease Control and Prevention (CDC) guidelines and definitions for diagnosing diarrhea—a symptom of CDI—in patients.

As per this strict definition, the patient is considered to experience diarrhea if they have ≥3 loose stools within 24 hours. Thomas stressed the importance of adhering to this guideline.

“From my experience, we would have a patient with 2 loose stools, and the nurse would be like, ‘Doc, I’ve sent off a stool sample for clostridium difficile and whole bunch of work-up — which is not supposed to be the case,” Thomas said.

She especially discouraged this among recently admitted patients who likely have not been on antibiotics for long or who have had little exposure with potential sources of C. diff.

“So, the CDC gave us a strict definition in terms of diarrhea, and I believe we should follow that and treat patients accordingly,” she emphasized.

Thomas also stressed for clinicians and healthcare providers to be mindful of the risk factors that may predispose a patient to C diff. This may include length of hospital stay, amount of diarrhea passed, or ethnic disparities—a consideration which she acknowledged should be examined more closely in future studies.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Christine Frissora, MD | Credit: Weill Cornell
Hope on the Horizon: 2 Food Allergy Breakthroughs in 2024
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Discussing FDA Approval of Tapinarof Cream for Atopic Dermatitis, with John Browning, MD
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
© 2024 MJH Life Sciences

All rights reserved.